RICARDO GONZALEZ: Open Payments
NPI 1508939687 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,711 in 76 payments from 12 companies in 2025. Trend: 2023 $2,551 · 2024 $4,085 · 2025 $2,711
Food & beverage: $2,488Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $834 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $482 |
| E.R. Squibb & Sons, L.L.C. | 6 | $229 |
| ABBVIE INC. | 12 | $221 |
| Neurocrine BioSciences, Inc. | 9 | $219 |
| Alkermes, Inc. | 10 | $217 |
| Janssen Pharmaceuticals, Inc | 3 | $183 |
| Axsome Therapeutics, Inc. | 5 | $182 |
| Lundbeck LLC | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: CAPLYTA, UZEDY, VRAYLAR, INGREZZA, ARISTADA, COBENFY, Auvelity, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
